24 October 2019 - 25 Tishri 5780 - כ"ה תשרי ה' אלפים תש"פ
Micromedic Technologies secures lucrative China distribution deal E-mail

Tel Aviv-based cancer diagnostic producer Micromedic Technologies has signed an exclusive distribution deal in China for its innovative bladder cancer detection platform, the company announced in October.

Micromedic manages the development of a variety of cancer diagnostic products, including its non-invasive CellDetect bladder product, which significantly enhances the diagnostic accuracy of early-stage bladder tumours. The deal is the company’s first distribution agreement in China. Under the agreement, Shanghai Gensource Medical Appliances – one of a group of jointly owned Chinese companies developing, producing and marketing medical and diagnostic apparatus – will distribute Micromedic’s product to the group’s customers in 25 cities across China and more than 8,000 hospitals and medical centres.

Shanghai Gensource has also finalised its first order from Micromedic, committing to a minimum purchase of diagnostic products worth approximately NIS 500,000 by the end of 2019. From 2020, the minimum purchase requirement will increase by 10% annually.

Please login or register to see the full article

Warning: Parameter 1 to modMainMenuHelper::buildXML() expected to be a reference, value given in /home/joomla789/domains/jewishtimesasia.org/public_html/libraries/joomla/cache/handler/callback.php on line 99
Jewish Times Asia is published by Jewish Times Asia Ltd. © Copyright 2019.
Material in the newspaper or on this site may not be used or reproduced in any form or in any way without permission from the editor.
While every effort has been made to ensure the content is true and accurate, the publisher is not responsible for any errors or omissions in the printed text.